Symbol | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
ANIP | Director | Dec 07, 2021 | Buy | $42.26 | 3,000 | 126,793 | 19,713 | Dec 09, 2021, 04:31 PM |
ENDP | President, Par Pharmaceutical | Apr 02, 2019 | Option Exercise | $8.10 | 11,669 | 94,519 | 65,648 | Apr 04, 2019, 04:36 PM |
ENDP | President, Par Pharmaceutical | Feb 23, 2019 | Option Exercise | $10.51 | 186 | 1,955 | 40,809 | Feb 26, 2019, 05:35 PM |
ENDP | President, Par Pharmaceutical | Feb 21, 2019 | Option Exercise | $10.38 | 2,528 | 26,241 | 40,423 | Feb 25, 2019, 04:49 PM |
ENDP | President, Par Pharmaceutical | Oct 01, 2018 | Option Exercise | $17.05 | 124 | 2,114 | 35,201 | Oct 02, 2018, 12:00 AM |
ENDP | President, Par Pharmaceutical | Aug 10, 2018 | Option Exercise | $15.82 | 5,585 | 88,355 | 34,968 | Aug 14, 2018, 04:09 PM |
ENDP | President, Par Pharmaceutical | Feb 23, 2018 | Option Exercise | $6.78 | 194 | 1,315 | 24,581 | Feb 27, 2018, 04:36 PM |
ENDP | President, Par Pharmaceutical | Feb 21, 2018 | Option Exercise | $6.72 | 3,117 | 20,946 | 24,203 | Feb 22, 2018, 06:48 PM |
ENDP | President, Par Pharmaceutical | Oct 01, 2017 | Option Exercise | $8.48 | 135 | 1,145 | 19,570 | Oct 02, 2017, 05:00 PM |
ENDP | President, Par Pharmaceutical | Feb 23, 2017 | Option Exercise | $13.22 | 247 | 3,265 | 19,348 | Feb 27, 2017, 02:53 PM |
Symbol | Relationship | Date | Transaction | Value($) |
ANIP | Director | Dec 07, 2021 | Buy | 126,793 |
ENDP | President, Par Pharmaceutical | Apr 02, 2019 | Option Exercise | 94,519 |
ENDP | President, Par Pharmaceutical | Feb 23, 2019 | Option Exercise | 1,955 |
ENDP | President, Par Pharmaceutical | Feb 21, 2019 | Option Exercise | 26,241 |
ENDP | President, Par Pharmaceutical | Oct 01, 2018 | Option Exercise | 2,114 |
ENDP | President, Par Pharmaceutical | Aug 10, 2018 | Option Exercise | 88,355 |
ENDP | President, Par Pharmaceutical | Feb 23, 2018 | Option Exercise | 1,315 |
ENDP | President, Par Pharmaceutical | Feb 21, 2018 | Option Exercise | 20,946 |
ENDP | President, Par Pharmaceutical | Oct 01, 2017 | Option Exercise | 1,145 |
ENDP | President, Par Pharmaceutical | Feb 23, 2017 | Option Exercise | 3,265 |